Home/Filings/4/0001209191-16-110105
4//SEC Filing

ARADIGM CORP 4

Accession 0001209191-16-110105

CIK 0001013238operating

Filed

Mar 21, 8:00 PM ET

Accepted

Mar 22, 7:35 PM ET

Size

7.2 KB

Accession

0001209191-16-110105

Insider Transaction Report

Form 4
Period: 2016-03-18
Froehlich Juergen Kurt
Chief Medical Officer
Transactions
  • Award

    Common Stock

    2016-03-18$4.04/sh+15,000$60,60086,308 total
  • Award

    Stock Option (Right to Buy)

    2016-03-18+13,00013,000 total
    Exercise: $4.04Exp: 2026-03-17Common Stock (13,000 underlying)
Footnotes (3)
  • [F1]Restricted stock award subject to repurchase by the Company, which repurchase right lapses quarterly over four years from March 18, 2016.
  • [F2]Stock option vests in equal quarterly installments over four years, vesting start date of 3/18/2016.
  • [F3]Inapplicable

Issuer

ARADIGM CORP

CIK 0001013238

Entity typeoperating
IncorporatedCA

Related Parties

1
  • filerCIK 0001013238

Filing Metadata

Form type
4
Filed
Mar 21, 8:00 PM ET
Accepted
Mar 22, 7:35 PM ET
Size
7.2 KB